Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Acasti Pharma (ACST)

Acasti Pharma (ACST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Acasti Pharma 3009 BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 CAN

P: 45-0687-2262 F: 450-686-2505

Description:

Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.

Key Statistics

Overview:

Market Capitalization, $K 36,943
Shares Outstanding, K 44,440
Annual Sales, $ 0 K
Annual Net Income, $ -9,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,900 K
60-Month Beta 1.78
% of Insider Shareholders 3.70%
% of Institutional Shareholders 0.46%
Float, K 42,796
% Float 96.30%
Short Volume Ratio 0.22

Growth:

1-Year Return -82.25%
3-Year Return -92.68%
5-Year Return -91.88%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 95.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 06/21/22
Next Earnings Date 08/11/22
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Qtr 55.56%
EPS Growth vs. Prev Year 83.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 08/31/21

ACST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.15%
Return-on-Assets % -9.28%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.35
Book Value/Share 2.44
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar